Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey A Porter

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Current Oncology (Toronto, Ont.)|December 23, 2021
Stakeholder-Identified Interventions to Address Cancer Survivors' Psychosocial Needs after Completing TreatmentSarah Murnaghan, Cynthia Kendell, Jonathan Sussman, et al.
Current Oncology (Toronto, Ont.)|August 26, 2021
What Matters in Cancer Survivorship Research? A Suite of Stakeholder-Relevant OutcomesRobin Urquhart, Sarah Murnaghan, Cynthia Kendell, et al.
CMAJ Open|August 30, 2016
Decision-making by surgeons about referral for adjuvant therapy for patients with non-small-cell lung, breast or colorectal cancer: a qualitative studyRobin Urquhart, Cynthia Kendell, Gordon Buduhan, et al.
Journal of Surgical Oncology|April 22, 2005
Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy marginsMartin Dzierzanowski, Karen A Melville, Penny J Barnes, et al.
Implementation Science : IS|October 27, 2012
How do surgeons decide to refer patients for adjuvant cancer treatment? Protocol for a qualitative studyRobin Urquhart, Cynthia Kendell, Joan Sargeant, et al.
Carcinogenesis|May 10, 2005
Polymorphisms in DNA repair genes in the molecular pathogenesis of esophageal (Barrett) adenocarcinomaAlan G Casson, Zuoyu Zheng, Susan C Evans, et al.
Molecular Carcinogenesis|September 13, 2007
Inducible nitric oxide synthase, nitrotyrosine and p53 mutations in the molecular pathogenesis of Barrett's esophagus and esophageal adenocarcinomaNadine M Vaninetti, Laurette Geldenhuys, Geoffrey A Porter, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 15, 2007
Alternative splicing of the FGF antisense gene: differential subcellular localization in human tissues and esophageal adenocarcinomaShuo Cheng Zhang, Christie Barclay, Leigh Ann Alexander, et al.
Molecular Carcinogenesis|May 5, 2007
Selective cyclooxygenase-2 inhibition suppresses basic fibroblast growth factor expression in human esophageal adenocarcinomaMark Baguma-Nibasheka, Christie Barclay, Audrey W Li, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 29, 2003
Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas: results of a ten-year prospective studyAlan G Casson, Susan C Evans, Amy Gillis, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Current Oncology (Toronto, Ont.)|December 23, 2021
Stakeholder-Identified Interventions to Address Cancer Survivors' Psychosocial Needs after Completing TreatmentSarah Murnaghan, Cynthia Kendell, Jonathan Sussman, et al.
Current Oncology (Toronto, Ont.)|August 26, 2021
What Matters in Cancer Survivorship Research? A Suite of Stakeholder-Relevant OutcomesRobin Urquhart, Sarah Murnaghan, Cynthia Kendell, et al.
CMAJ Open|August 30, 2016
Decision-making by surgeons about referral for adjuvant therapy for patients with non-small-cell lung, breast or colorectal cancer: a qualitative studyRobin Urquhart, Cynthia Kendell, Gordon Buduhan, et al.
Journal of Surgical Oncology|April 22, 2005
Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy marginsMartin Dzierzanowski, Karen A Melville, Penny J Barnes, et al.
Implementation Science : IS|October 27, 2012
How do surgeons decide to refer patients for adjuvant cancer treatment? Protocol for a qualitative studyRobin Urquhart, Cynthia Kendell, Joan Sargeant, et al.
Carcinogenesis|May 10, 2005
Polymorphisms in DNA repair genes in the molecular pathogenesis of esophageal (Barrett) adenocarcinomaAlan G Casson, Zuoyu Zheng, Susan C Evans, et al.
Molecular Carcinogenesis|September 13, 2007
Inducible nitric oxide synthase, nitrotyrosine and p53 mutations in the molecular pathogenesis of Barrett's esophagus and esophageal adenocarcinomaNadine M Vaninetti, Laurette Geldenhuys, Geoffrey A Porter, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 15, 2007
Alternative splicing of the FGF antisense gene: differential subcellular localization in human tissues and esophageal adenocarcinomaShuo Cheng Zhang, Christie Barclay, Leigh Ann Alexander, et al.
Molecular Carcinogenesis|May 5, 2007
Selective cyclooxygenase-2 inhibition suppresses basic fibroblast growth factor expression in human esophageal adenocarcinomaMark Baguma-Nibasheka, Christie Barclay, Audrey W Li, et al.
The Journal of Thoracic and Cardiovascular Surgery|May 29, 2003
Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas: results of a ten-year prospective studyAlan G Casson, Susan C Evans, Amy Gillis, et al.
Pageof 4